Old Web
English
Sign In
Acemap
>
authorDetail
>
James Hartke
James Hartke
Celgene
Medicine
Clinical trial
Biology
Cancer research
Pharmacology
8
Papers
189
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of Therapeutics for Severely‐Debilitating or Life Threatening Diseases or Conditions: Defining Scope to Enable Global Guidance Development
2019
Clinical Pharmacology & Therapeutics
Maggie Liu
F. Owen Fields
Judith S. Prescott
Akintunde Bello
Nancy Bower
Salima Darakjy
James Hartke
Vivek J. Kadambi
Daniel Lapadula
Aubrey Stoch
Mazin Derzi
Show All
Source
Cite
Save
Citations (3)
An Industry Perspective on the 2017 EMA Guideline on First‐in‐Human and Early Clinical Trials
2018
Clinical Pharmacology & Therapeutics
Joseph J. DeGeorge
Sarah Robertson
Lynne Butler
Mazin Derzi
S. Aubrey Stoch
Dolores Díaz
James Hartke
Peggy Guzzie-Peck
Elisabeth Mortimer‐Cassen
Matthew S. Bogdanffy
Yvonne Will
Nigel Greene
Show All
Source
Cite
Save
Citations (1)
Overview of the “Epigenetic End Points in Toxicologic Pathology and Relevance to Human Health” Session of the 2014 Society of Toxicologic Pathology Annual Symposium
2015
Toxicologic Pathology
Mark J. Hoenerhoff
James Hartke
Show All
Source
Cite
Save
Citations (1)
Preclinical development of agents for the treatment of osteoporosis.
1999
Toxicologic Pathology
James Hartke
Show All
Source
Cite
Save
Citations (25)
1